Y. Zhou, D. M. Boudreau, and A. N. Freedman, Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population, Pharmacoepidemiology and Drug Safety, vol.23, issue.1, pp.43-50, 2013.

C. Ohm, A. Mina, G. Howells, H. Bair, and P. Bendick, Effects of Antiplatelet Agents on Outcomes for Elderly Patients With Traumatic Intracranial Hemorrhage, The Journal of Trauma: Injury, Infection, and Critical Care, vol.58, issue.3, pp.518-522, 2005.

D. K. Wong, F. Lurie, and L. L. Wong, The Effects of Clopidogrel on Elderly Traumatic Brain Injured Patients, The Journal of Trauma: Injury, Infection, and Critical Care, vol.65, issue.6, pp.1303-1308, 2008.

J. Fan, H. Huang, Y. Chen, D. Yen, W. Kao et al., Emergency Department Neurologic Deterioration in Patients With Spontaneous Intracerebral Hemorrhage: Incidence, Predictors, and Prognostic Significance, Academic Emergency Medicine, vol.19, issue.2, pp.133-138, 2012.

C. L. Van-den-brand, T. Tolido, A. H. Rambach, M. G. Hunink, P. Patka et al., Systematic Review and Meta-Analysis: Is Pre-Injury Antiplatelet Therapy Associated with Traumatic Intracranial Hemorrhage?, Journal of Neurotrauma, vol.34, issue.1, pp.1-7, 2017.

A. Fabbri, F. Servadei, G. Marchesini, C. Bronzoni, D. Montesi et al., Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study, Critical Care, vol.17, issue.2, p.R53, 2013.

C. E. Lovelock, A. J. Molyneux, and P. M. Rothwell, Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study, The Lancet Neurology, vol.6, issue.6, pp.487-493, 2007.

, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, The Lancet, vol.373, issue.9678, pp.1849-1860, 2009.

A. M. Naidech, B. Jovanovic, S. Liebling, R. K. Garg, S. L. Bassin et al., Reduced Platelet Activity Is Associated With Early Clot Growth and Worse 3-Month Outcome After Intracerebral Hemorrhage, Stroke, vol.40, issue.7, pp.2398-2401, 2009.

S. M. Davis, J. Broderick, M. Hennerici, N. C. Brun, M. N. Diringer et al., Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage, Neurology, vol.66, issue.8, pp.1175-1181, 2006.

J. Alvikas, S. P. Myers, C. B. Wessel, D. O. Okonkwo, B. Joseph et al., A systematic review and meta-analysis of traumatic intracranial hemorrhage in patients taking prehospital antiplatelet therapy: Is there a role for platelet transfusions?, Journal of Trauma and Acute Care Surgery, vol.88, issue.6, pp.847-854, 2020.

A. Martin, S. Houssany-pissot, D. Zlotnik, G. Taylor, and A. Godier, Prise en charge du risque hémorragique associé aux agents antiplaquettaires, La Revue de Médecine Interne, vol.38, issue.7, pp.467-473, 2017.

, Littérature commentée janvier 2016, La Revue de Médecine Interne, vol.38, issue.1, pp.73-75, 2017.

C. Hindy-françois, C. Bachelot-loza, B. L. Bonniec, F. Grelac, B. Dizier et al., Recombinant activated factor VII does not reduce bleeding in rabbits treated with aspirin and clopidogrel, Thrombosis and Haemostasis, vol.104, issue.10, pp.823-830, 2010.

D. L. Bhatt, C. V. Pollack, J. I. Weitz, L. K. Jennings, S. Xu et al., Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers, New England Journal of Medicine, vol.380, issue.19, pp.1825-1833, 2019.

M. M. Hovens, J. D. Snoep, J. C. Eikenboom, J. G. Van-der-bom, B. J. Mertens et al., Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review, American Heart Journal, vol.153, issue.2, pp.175-181, 2007.

D. Aradi, R. F. Storey, A. Komócsi, D. Trenk, D. Gulba et al., Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention, European Heart Journal, vol.35, issue.4, pp.209-215, 2013.

R. Paniccia, E. Antonucci, N. Maggini, E. Romano, A. M. Gori et al., Assessment of Platelet Function on Whole Blood by Multiple Electrode Aggregometry in High-Risk Patients With Coronary Artery Disease Receiving Antiplatelet Therapy, American Journal of Clinical Pathology, vol.131, issue.6, pp.834-842, 2009.

C. Velik-salchner, S. Maier, P. Innerhofer, W. Streif, A. Klingler et al., Point-of-Care Whole Blood Impedance Aggregometry Versus Classical Light Transmission Aggregometry for Detecting Aspirin and Clopidogrel: The Results of a Pilot Study, Anesthesia & Analgesia, vol.107, issue.6, pp.1798-1806, 2008.

J. Ulehlova, L. Slavik, V. Krcova, M. Hutyra, J. Galuszka et al., The assessment of aspirin resistance by using light transmission and multiple electrode aggregometry, International Journal of Laboratory Hematology, vol.33, issue.3, pp.305-309, 2011.

D. L. Mcglasson and G. A. Fritsma, Whole Blood Platelet Aggregometry and Platelet Function Testing, Seminars in Thrombosis and Hemostasis, vol.35, issue.02, pp.168-180, 2009.

H. Riess, G. Braun, G. Brehm, and E. Hiller, Critical Evaluation of Platelet Aggregation in Whole Human Blood, American Journal of Clinical Pathology, vol.85, issue.1, pp.50-56, 1986.

S. B. Pedersen, E. L. Grove, H. L. Nielsen, J. Mortensen, S. D. Kristensen et al., Evaluation of aspirin response by Multiplate® whole blood aggregometry and light transmission aggregometry, Platelets, vol.20, issue.6, pp.415-420, 2009.

A. Dyszkiewicz-korpanty, H. Olteanu, E. P. Frenkel, and R. Sarode, Clopidogrel anti-platelet effect: An evaluation by optical aggregometry, impedance aggregometry, and the Platelet Function Analyzer (PFA-100?), Platelets, vol.18, issue.7, pp.491-496, 2007.

A. Godier, D. Garrigue, D. Lasne, P. Fontana, F. Bonhomme et al., Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), Anaesthesia Critical Care & Pain Medicine, vol.38, issue.3, pp.289-302, 2019.

J. A. Frontera, J. J. Lewin-iii, A. A. Rabinstein, I. P. Aisiku, A. W. Alexandrov et al., Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage, Neurocritical Care, vol.24, issue.1, pp.6-46, 2015.

Y. Zhou, D. M. Boudreau, and A. N. Freedman, Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population, Pharmacoepidemiology and Drug Safety, vol.23, issue.1, pp.43-50, 2013.

P. V. Giannoudis, P. J. Harwood, C. Court-brown, and H. C. Pape, Severe and multiple trauma in older patients; incidence and mortality, Injury, vol.40, issue.4, pp.362-367, 2009.

C. E. Lovelock, A. J. Molyneux, and P. M. Rothwell, Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study, The Lancet Neurology, vol.6, issue.6, pp.487-493, 2007.

N. Ahmed, C. Bialowas, Y. Kuo, and L. Zawodniak, Impact of Preinjury Anticoagulation in Patients with Traumatic Brain Injury, Southern Medical Journal, vol.102, issue.5, pp.476-480, 2009.

G. R. Fortuna, E. W. Mueller, L. E. James, L. A. Shutter, and K. L. Butler, The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury, Surgery, vol.144, issue.4, pp.598-605, 2008.

L. H. Sansing, S. R. Messe, B. L. Cucchiara, S. N. Cohen, P. D. Lyden et al., Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH, Neurology, vol.72, issue.16, pp.1397-1402, 2009.

M. Moussouttas, R. Malhotra, L. Fernandez, M. Maltenfort, M. Holowecki et al., Role of Antiplatelet Agents in Hematoma Expansion During The Acute Period of Intracerebral Hemorrhage, Neurocritical Care, vol.12, issue.1, pp.24-29, 2009.

C. Ohm, A. Mina, G. Howells, H. Bair, and P. Bendick, Effects of Antiplatelet Agents on Outcomes for Elderly Patients With Traumatic Intracranial Hemorrhage, The Journal of Trauma: Injury, Infection, and Critical Care, vol.58, issue.3, pp.518-522, 2005.

D. K. Wong, F. Lurie, and L. L. Wong, The Effects of Clopidogrel on Elderly Traumatic Brain Injured Patients, The Journal of Trauma: Injury, Infection, and Critical Care, vol.65, issue.6, pp.1303-1308, 2008.

J. Fan, H. Huang, Y. Chen, D. Yen, W. Kao et al., Emergency Department Neurologic Deterioration in Patients With Spontaneous Intracerebral Hemorrhage: Incidence, Predictors, and Prognostic Significance, Academic Emergency Medicine, vol.19, issue.2, pp.133-138, 2012.

C. L. Brand, T. Tolido, A. H. Rambach, M. Hunink, P. Patka et al., Systematic Review and Meta-Analysis: Is Pre-Injury Antiplatelet Therapy Associated with Traumatic Intracranial Hemorrhage?, J Neurotrauma, vol.34, issue.1, pp.1-7, 201701.

A. Fabbri, F. Servadei, G. Marchesini, C. Bronzoni, D. Montesi et al., Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study, Critical Care, vol.17, issue.2, p.R53, 2013.

, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, The Lancet, vol.373, issue.9678, pp.1849-1860, 2009.

A. M. Naidech, B. Jovanovic, S. Liebling, R. K. Garg, S. L. Bassin et al., Reduced Platelet Activity Is Associated With Early Clot Growth and Worse 3-Month Outcome After Intracerebral Hemorrhage, Stroke, vol.40, issue.7, pp.2398-2401, 2009.

S. M. Davis, J. Broderick, M. Hennerici, N. C. Brun, M. N. Diringer et al., Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage, Neurology, vol.66, issue.8, pp.1175-1181, 2006.

M. A. Kumar, Coagulopathy Associated with Traumatic Brain Injury, Current Neurology and Neuroscience Reports, vol.13, issue.11, p.391, 2013.

T. Geeraerts, W. Haïk, B. Tremey, J. Duranteau, and B. Vigué, Troubles de la coagulation lors du traumatisme cranio-encéphalique : physiopathologie et conséquences thérapeutiques, Annales Françaises d'Anesthésie et de Réanimation, vol.29, issue.9, pp.e177-e181, 2010.

B. S. Harhangi, E. J. Kompanje, F. W. Leebeek, and A. I. Maas, Coagulation disorders after traumatic brain injury, Acta Neurochirurgica, vol.150, issue.2, pp.165-175, 2008.

J. Alvikas, S. P. Myers, C. B. Wessel, D. O. Okonkwo, B. Joseph et al., A systematic review and meta-analysis of traumatic intracranial hemorrhage in patients taking prehospital antiplatelet therapy: Is there a role for platelet transfusions?, Journal of Trauma and Acute Care Surgery, vol.88, issue.6, pp.847-854, 2020.

M. I. Baharoglu, C. Cordonnier, R. Salman, K. De-gans, M. M. Koopman et al., Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial, The Lancet, vol.387, issue.10038, pp.2605-2613, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01561017

A. Martin, S. Houssany-pissot, D. Zlotnik, G. Taylor, and A. Godier, Prise en charge du risque hémorragique associé aux agents antiplaquettaires, La Revue de Médecine Interne, vol.38, issue.7, pp.467-473, 2017.

, Littérature commentée janvier 2016, La Revue de Médecine Interne, vol.38, issue.1, pp.73-75, 2017.

C. Hindy-françois, C. Bachelot-loza, B. L. Bonniec, F. Grelac, B. Dizier et al., Recombinant activated factor VII does not reduce bleeding in rabbits treated with aspirin and clopidogrel, Thrombosis and Haemostasis, vol.104, issue.10, pp.823-830, 2010.

A. Godier, D. Garrigue, D. Lasne, P. Fontana, F. Bonhomme et al., Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), Anaesthesia Critical Care & Pain Medicine, vol.38, issue.3, pp.289-302, 2019.

E. C. Hansson, C. Shams-hakimi, K. Åström-olsson, C. Hesse, H. Wallén et al., Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor, British Journal of Anaesthesia, vol.112, issue.3, pp.570-575, 2014.

G. Taylor, D. Osinski, A. Thevenin, and J. Devys, Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery?, Journal of Trauma and Acute Care Surgery, vol.74, issue.5, pp.1367-1369, 2013.

. Caprie-steering-committee, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), The Lancet, vol.348, issue.9038, pp.1329-1339, 1996.

S. Yusuf, F. Zhao, S. R. Mehta, S. Chrolavicius, G. Tognoni et al., Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation, New England Journal of Medicine, vol.345, issue.7, pp.494-502, 2001.

S. D. Wiviott, E. M. Antman, C. M. Gibson, G. Montalescot, J. Riesmeyer et al., Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38), American Heart Journal, vol.152, issue.4, pp.627-635, 2006.

C. Li, J. Hirsh, C. Xie, M. A. Johnston, and J. W. Eikelboom, Reversal of the anti-platelet effects of aspirin and clopidogrel, Journal of Thrombosis and Haemostasis, vol.10, issue.4, pp.521-528, 2012.

L. Schoener, S. Jellinghaus, B. Richter, C. Pfluecke, G. Ende et al., Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue, Clinical Research in Cardiology, vol.106, issue.11, pp.868-874, 2017.

O. Stephen, A. , A. Julien, M. Anne, M. Réjane et al., Efficacy of Ex Vivo Autologous and In Vivo Platelet Transfusion in the Reversal of P2Y12 Inhibition by Clopidogrel, Prasugrel, and Ticagrelor, Circ Cardiovasc Interv, vol.8, issue.11, p.2786, 2015.

N. Ferri, A. Corsini, and S. Bellosta, Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties, Drugs, vol.73, issue.15, pp.1681-1709, 2013.

P. P. Dobesh and J. H. Oestreich, Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol.34, issue.10, pp.1077-1090, 2014.

R. F. Storey, K. P. Bliden, R. Ecob, A. Karunakaran, K. Butler et al., Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses, Journal of Thrombosis and Haemostasis, vol.9, issue.9, pp.1730-1737, 2011.

M. U. Zafar, D. A. Smith, U. Baber, S. Sartori, K. Chen et al., Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With Ticagrelor, Circulation: Cardiovascular Interventions, vol.10, issue.8, p.5120, 2017.

A. Martin, C. Berndt, L. Calmette, I. Philip, B. Decouture et al., The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation, European Journal of Anaesthesiology, vol.33, issue.5, pp.361-367, 2016.

A. T. Collaboration, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, vol.324, issue.7329, pp.71-86, 2002.

A. Weber, B. Przytulski, A. Schanz, T. Hohlfeld, and K. Schrör, Towards a definition of aspirin resistance: a typological approach, Platelets, vol.13, issue.1, pp.37-40, 2002.

A. O. Maree, R. J. Curtin, A. Chubb, C. Dolan, D. Cox et al., Cyclooxygenase-1 haplotype modulates platelet response to aspirin, Journal of Thrombosis and Haemostasis, vol.3, issue.10, pp.2340-2345, 2005.

L. Fan, J. Cao, L. Liu, X. Li, G. Hu et al., Frequency, Risk Factors, Prognosis, and Genetic Polymorphism of the Cyclooxygenase-1 Gene for Aspirin Resistance in Elderly Chinese Patients with Cardiovascular Disease, Gerontology, vol.59, issue.2, pp.122-131, 2013.

Z. Weng, X. Li, Y. Li, J. Lin, F. Peng et al., The Association of Four Common Polymorphisms from Four Candidate Genes (COX-1, COX-2, ITGA2B, ITGA2) with Aspirin Insensitivity: A Meta-Analysis, PLoS ONE, vol.8, issue.11, p.e78093, 2013.

L. Liu, Y. Gao, J. Cao, H. Zhang, F. L. Hu et al., High prevalence of aspirin resistance in elderly patients with cardiovascular disease and metabolic syndrome, J Geriatr Cardiol JGC, vol.13, issue.6, pp.531-537, 2016.

C. Kasmeridis, S. Apostolakis, and G. Y. Lip, Aspirin and aspirin resistance in coronary artery disease, Current Opinion in Pharmacology, vol.13, issue.2, pp.242-250, 2013.

D. T. Ertugrul, E. Tutal, M. Y?ld?z, O. Akin, A. A. Yalç?n et al., Aspirin Resistance Is Associated with Glycemic Control, the Dose of Aspirin, and Obesity in Type 2 Diabetes Mellitus, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.6, pp.2897-2901, 2010.

I. L. Meek, H. E. Vonkeman, J. Kasemier, K. L. Movig, and M. A. Van-de-laar, Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: A placebo-controlled, ex vivo, serial placebo-controlled serial crossover study, European Journal of Clinical Pharmacology, vol.69, issue.3, pp.365-371, 2012.

W. Kuliczkowski, A. Witkowski, L. Polonski, C. Watala, K. Filipiak et al., Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology, European Heart Journal, vol.30, issue.4, pp.426-435, 2008.

M. M. Hovens, J. D. Snoep, J. C. Eikenboom, J. G. Van-der-bom, B. J. Mertens et al., Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review, American Heart Journal, vol.153, issue.2, pp.175-181, 2007.

S. Ray, Clopidogrel resistance: The way forward, Indian Heart Journal, vol.66, issue.5, pp.530-534, 2014.

L. Bonello, U. S. Tantry, R. Marcucci, R. Blindt, D. J. Angiolillo et al., Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate, Journal of the American College of Cardiology, vol.56, issue.12, pp.919-933, 2010.

D. Sibbing, R. A. Byrne, I. Bernlochner, and A. Kastrati, High platelet reactivity and clinical outcome ? Fact and fiction, Thrombosis and Haemostasis, vol.106, issue.08, pp.191-202, 2011.

I. Bernlochner, S. Steinhubl, S. Braun, T. Morath, J. Jaitner et al., Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment, Thrombosis and Haemostasis, vol.104, issue.12, pp.1193-1200, 2010.

T. Geisler, N. Anders, M. Paterok, H. Langer, K. Stellos et al., Platelet Response to Clopidogrel Is Attenuated in Diabetic Patients Undergoing Coronary Stent Implantation, Diabetes Care, vol.30, issue.2, pp.372-374, 2007.

V. Serebruany, G. Cherala, C. Williams, S. Surigin, C. Booze et al., Association of platelet responsiveness with clopidogrel metabolism: Role of compliance in the assessment of ?resistance?, American Heart Journal, vol.158, issue.6, pp.925-932, 2009.

J. L. Mega, T. Simon, J. Collet, J. L. Anderson, E. M. Antman et al., Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI, JAMA, vol.304, issue.16, p.1821, 2010.

L. Wallentin, R. C. Becker, A. Budaj, C. P. Cannon, H. Emanuelsson et al., Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.361, issue.11, pp.1045-1057, 2009.

K. Birkeland, D. Parra, and R. Rosenstein, Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor, J Blood Med, vol.1, pp.197-219, 2010.

A. M. Quidley and K. Whyte, 156, Critical Care Medicine, vol.46, issue.1, p.61, 2018.

M. R. Thomas and R. F. Storey, Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitors, Vascular Pharmacology, vol.84, pp.25-27, 2016.

D. R. Spahn, B. Bouillon, V. Cerny, J. Duranteau, D. Filipescu et al., The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition, Critical Care, vol.23, issue.1, p.98, 2019.

R. Paniccia, E. Antonucci, N. Maggini, E. Romano, A. M. Gori et al., Assessment of Platelet Function on Whole Blood by Multiple Electrode Aggregometry in High-Risk Patients With Coronary Artery Disease Receiving Antiplatelet Therapy, American Journal of Clinical Pathology, vol.131, issue.6, pp.834-842, 2009.

J. Ulehlova, L. Slavik, V. Krcova, M. Hutyra, J. Galuszka et al., The assessment of aspirin resistance by using light transmission and multiple electrode aggregometry, International Journal of Laboratory Hematology, vol.33, issue.3, pp.305-309, 2011.

S. B. Pedersen, E. L. Grove, H. L. Nielsen, J. Mortensen, S. D. Kristensen et al., Evaluation of aspirin response by Multiplate® whole blood aggregometry and light transmission aggregometry, Platelets, vol.20, issue.6, pp.415-420, 2009.

. Beckerath-n-von, A. Kastrati, A. Schömig, J. Mehilli, W. Vogt et al., Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment, Thromb Haemost, vol.99, issue.01, pp.121-127, 2017.

A. Dyszkiewicz-korpanty, H. Olteanu, E. P. Frenkel, and R. Sarode, Clopidogrel anti-platelet effect: An evaluation by optical aggregometry, impedance aggregometry, and the Platelet Function Analyzer (PFA-100?), Platelets, vol.18, issue.7, pp.491-496, 2007.

C. Velik-salchner, S. Maier, P. Innerhofer, W. Streif, A. Klingler et al., Point-of-Care Whole Blood Impedance Aggregometry Versus Classical Light Transmission Aggregometry for Detecting Aspirin and Clopidogrel: The Results of a Pilot Study, Anesthesia & Analgesia, vol.107, issue.6, pp.1798-1806, 2008.

C. Beynon, M. Scherer, M. Jakobs, C. Jung, O. W. Sakowitz et al., Initial experiences with Multiplate® for rapid assessment of antiplatelet agent activity in neurosurgical emergencies, Clinical Neurology and Neurosurgery, vol.115, issue.10, pp.2003-2008, 2013.

A. Briggs, J. D. Gates, R. M. Kaufman, C. Calahan, W. B. Gormley et al., Platelet dysfunction and platelet transfusion in traumatic brain injury, Journal of Surgical Research, vol.193, issue.2, pp.802-806, 2015.

X. Li, Z. Sun, W. Zhao, J. Zhang, J. Chen et al., Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage, Journal of Neurosurgery, vol.118, issue.1, pp.94-103, 2013.

F. Bonhomme, The role of point-of-care platelet function testing in guiding platelet transfusion

, Buchbesprechungen–Book Reviews, Transfusion Medicine and Hemotherapy, vol.18, issue.4, pp.202-202, 1991.

L. Chen, A. W. Bracey, R. Radovancevic, J. R. Cooper, C. D. Collard et al., Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting, The Journal of Thoracic and Cardiovascular Surgery, vol.128, issue.3, pp.425-431, 2004.

C. F. Weber, K. Görlinger, D. Meininger, E. Hermann, T. Bingold et al., Point of Care Testing, Survey of Anesthesiology, vol.57, issue.4, p.167, 2013.

C. Corredor, M. Wasowicz, K. Karkouti, and V. Sharma, The role of point-of-care platelet function testing in predicting postoperative bleeding following cardiac surgery: a systematic review and meta-analysis, Anaesthesia, vol.70, issue.6, pp.715-731, 2015.

J. A. Frontera, J. J. Lewin-iii, A. A. Rabinstein, I. P. Aisiku, A. W. Alexandrov et al., Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage, Neurocritical Care, vol.24, issue.1, pp.6-46, 2015.

C. A. Pelaez, S. K. Spilman, C. T. Bell, D. K. Eastman, and R. A. Sidwell, Not all head injured patients on antiplatelet drugs need platelets: Integrating platelet reactivity testing into platelet transfusion guidelines, Injury, vol.50, issue.1, pp.73-78, 2019.

A. R. Guillotte, J. P. Herbert, R. Madsen, R. D. Hammer, and N. S. Litofsky, Effects of platelet dysfunction and platelet transfusion on outcomes in traumatic brain injury patients, Brain Injury, vol.32, issue.13-14, pp.1849-1857, 2018.

A. D. Mendelow, B. A. Gregson, H. M. Fernandes, G. D. Murray, G. M. Teasdale et al., Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial, The Lancet, vol.365, issue.9457, pp.387-397, 2005.

A. D. Mendelow, B. A. Gregson, E. N. Rowan, G. D. Murray, A. Gholkar et al., Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial, The Lancet, vol.382, issue.9890, pp.397-408, 2013.

A. F. Ducruet, Z. L. Hickman, B. E. Zacharia, B. T. Grobelny, P. A. Derosa et al., Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage, Neurological Research, vol.32, issue.7, pp.706-710, 2010.

D. M. Downey, B. Monson, K. L. Butler, G. R. Fortuna, J. M. Saxe et al., Does Platelet Administration Affect Mortality in Elderly Head-Injured Patients Taking Antiplatelet Medications?, The American Surgeon, vol.75, issue.11, pp.1100-1103, 2009.

C. W. Washington, D. J. Schuerer, and R. L. Grubb, Platelet Transfusion: An Unnecessary Risk for Mild Traumatic Brain Injury Patients on Antiplatelet Therapy, The Journal of Trauma: Injury, Infection, and Critical Care, vol.71, issue.2, pp.358-363, 2011.

F. A. Ivascu, G. A. Howells, F. S. Junn, H. A. Bair, P. J. Bendick et al., Predictors of Mortality in Trauma Patients With Intracranial Hemorrhage on Preinjury Aspirin or Clopidogrel, The Journal of Trauma: Injury, Infection, and Critical Care, vol.65, issue.4, pp.785-788, 2008.

D. Aradi, R. F. Storey, A. Komócsi, D. Trenk, D. Gulba et al., Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention, European Heart Journal, vol.35, issue.4, pp.209-215, 2013.

U. S. Tantry, L. Bonello, D. Aradi, M. J. Price, Y. Jeong et al., Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding, Journal of the American College of Cardiology, vol.62, issue.24, pp.2261-2273, 2013.

D. Aradi, J. Collet, J. Mair, M. Plebani, B. Merkely et al., Platelet function testing in acute cardiac care -is there a role for prediction or prevention of stent thrombosis and bleeding? Thromb Haemost, vol.113, pp.221-251, 2015.

C. Jámbor, C. F. Weber, K. Gerhardt, W. K. Dietrich, M. Spannagl et al., Whole Blood Multiple Electrode Aggregometry Is a Reliable Point-of-Care Test of Aspirin-Induced Platelet Dysfunction, Anesthesia & Analgesia, vol.109, issue.1, pp.25-31, 2009.

A. Calatzis, N. Rahe-meyer, F. Theisen, and M. Spannagl, Detection of aspirin and clopidogrel using multiple electrode aggregometry, European Journal of Anaesthesiology, vol.24, issue.Supplement 39, p.67, 2007.

M. Kozi?ski, M. Ostrowska, P. Adamski, J. Sikora, A. Sikora et al., Which platelet function test best reflects the in vivo plasma concentrations of ticagrelor and its active metabolite?: The HARMONIC study, Thromb Haemost, vol.116, issue.12, pp.1140-1149, 2016.

D. Sibbing, S. Braun, T. Morath, J. Mehilli, W. Vogt et al., Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis, Journal of the American College of Cardiology, vol.53, issue.10, pp.849-856, 2009.

D. Sibbing, S. Schulz, S. Braun, T. Morath, J. Stegherr et al., Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement, Journal of Thrombosis and Haemostasis, vol.8, issue.2, pp.250-256, 2010.

C. Lindblad, E. P. Thelin, M. Nekludov, A. Frostell, D. W. Nelson et al., Assessment of Platelet Function in Traumatic Brain Injury?A Retrospective Observational Study in the Neuro-Critical Care Setting, Frontiers in Neurology, vol.9, p.15, 2018.

P. A. Choi, P. V. Parry, J. S. Bauer, B. E. Zusman, D. M. Panczykowski et al., Use of Aspirin and P2Y12 Response Assays in Detecting Reversal of Platelet Inhibition With Platelet Transfusion in Patients With Traumatic Brain Injury on Antiplatelet Therapy, Neurosurgery, p.1, 2016.

A. M. Bachelani, J. T. Bautz, J. L. Sperry, A. Corcos, M. Zenati et al., Assessment of platelet transfusion for reversal of aspirin after traumatic brain injury, Surgery, vol.150, issue.4, pp.836-843, 2011.

A. Godier, G. Taylor, and P. Gaussem, Inefficacy of Platelet Transfusion to Reverse Ticagrelor, New England Journal of Medicine, vol.372, issue.2, pp.196-197, 2015.

D. L. Bhatt, C. V. Pollack, J. I. Weitz, L. K. Jennings, S. Xu et al., Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers, New England Journal of Medicine, vol.380, issue.19, pp.1825-1833, 2019.

A. Abaci, Y. Yilmaz, M. Caliskan, F. Bayram, M. Cetin et al., Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes, Thrombosis Research, vol.116, issue.6, pp.465-470, 2005.

K. Von-pape, G. Strupp, T. Bonzel, and J. Bohner, Effect of compliance and dosage adaptation of long term aspirin on platelet function with PFA-100 in patients after myocardial infarction, Thrombosis and Haemostasis, vol.94, issue.4, pp.889-891, 2005.

P. Lee, W. Chen, W. Ng, X. Cheng, J. Kwok et al., Low-dose aspirin increases aspirin resistance in patients with coronary artery disease, The American Journal of Medicine, vol.118, issue.7, pp.723-727, 2005.

J. M. Siller-matula, A. Hintermeier, J. Kastner, G. Kreiner, G. Maurer et al., Distribution of clinical events across platelet aggregation values in all-comers treated with prasugrel and ticagrelor, Vascular Pharmacology, vol.79, pp.6-10, 2016.

D. Alexopoulos, K. Stavrou, I. Koniari, V. Gkizas, A. Perperis et al., Ticagrelor vs prasugrel one-month maintenance therapy: impact on platelet reactivity and bleeding events, Thromb Haemost, vol.112, issue.3, pp.551-558, 2014.

R. F. Storey, D. J. Angiolillo, S. B. Patil, B. Desai, R. Ecob et al., Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes, Journal of the American College of Cardiology, vol.56, issue.18, pp.1456-1462, 2010.

M. Baschin, S. Selleng, A. Hummel, S. Diedrich, H. W. Schroeder et al., Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non?cardiac surgery: an observational cohort study, Journal of Thrombosis and Haemostasis, vol.16, issue.4, pp.709-717, 2018.

F. Perelvaig, Travail multitâche, sécurité des soins et bien-être au travail, La Revue de l'Infirmière, vol.69, issue.263, pp.35-36, 2020.

, 3.1.1. Emploi dans le secteur de la santé et des services sociaux en pourcentage de l'emploi civil total, 1995 et 2009 (ou année la plus proche)

. Prâevost, Â. M. Chomprâe, A. Deleyre, J. Green, A. Meusnier-de-querlon et al., Histoire gâenâerale des voyages, ou, Nouvelle collection de toutes les relations de voyages par mer et par terre, qui ont âetâe publiâees jusqu'áa present dans les diffâerentes langues de toutes les nations connues : contenant ce qu'il y a de plus remarquable, de plus utile et de mieux averâe dans les pays ou les voyageurs ont penetrâe : touchant leur situation, leur âetendue, leurs limites, leurs divisions, leur climat, leur terroir, leurs productions, leurs lacs, leurs rivieres, leurs montagnes, leurs mines, leurs citâes & leurs principales villes, leurs ports, leurs rades, leurs edifices, &c. : avec les moeurs et les usages des habitans, leur religion, leur gouvernement, leurs arts et leurs sciences, leur commerce et leurs manufactures : pour former un systâeme complet d'histoire et de gâeographie moderne, qui representera l'âetat actuel de toutes les nations : enrichi de cartes gâeographiques nouvellement composâees sur les observations les plus autentiques :, 1746.

, Graphique 10.7. Les migrants très instruits ne sont pas les plus enclins à regagner leur pays d'origine, et ce pour la plupart des pays

, Comment puis-je me tenir informé des technologies les plus récentes, des nouveaux modèles de fabrication, et de la recherche-développement?, 2003.

L. Madsen-brooks, « Je ne me suis pas perdue et ne souhaite pas que l?on me trouve ». Stratégies des femmes dans les musées de sciences en Californie (xixe-, Culture & musées, issue.30, pp.111-131, 2017.

M. Sandras, « Je ne suis pas un écrivain, je suis le poète qui chante » Les entretiens de Paul Fort avec Michel Manoll, Écrivains au micro, pp.201-15

M. Sandras, « Je ne suis pas un écrivain, je suis le poète qui chante » Les entretiens de Paul Fort avec Michel Manoll, Écrivains au micro, pp.201-15

A. Niess, Conclusion. Le spectre des deux-cents familles ?, L?hérédité en République, pp.327-328, 2012.

M. Demélas-bohy, «Je suis oiseau ; voyez mes ailes...», «Je suis souris : vive les rats !», Caravelle, vol.62, issue.1, pp.179-191, 1994.

. Sean, « Faites que demain je sois », Interbloc, vol.33, issue.2, pp.124-127, 2014.